Atossa Therapeutics Inc (ATOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Sales | 326 | 183 | 99 | 106 | 223 |
| Cost of Goods | 222 | 67 | 6 | 15 | 18 |
| Gross Profit | 104 | 116 | 93 | 91 | 205 |
| Operating Expenses | 2,909 | 2,124 | 1,804 | 1,241 | 1,389 |
| Operating Income | -2,583 | -1,941 | -1,705 | -1,136 | -1,166 |
| Interest Expense | 0 | 0 | 0 | 8 | 2 |
| Pre-tax Income | -2,584 | -1,941 | -1,706 | -1,143 | -1,168 |
| Net Income Continuous | -2,584 | -1,941 | -1,706 | -1,143 | -1,168 |
| Net Income | $-2,584 | $-1,941 | $-1,706 | $-1,143 | $-1,168 |
| EPS Basic Total Ops | -30.60 | -25.20 | -21.60 | -18.00 | -18.00 |
| EPS Basic Continuous Ops | -31.40 | -26.04 | -19.47 | -18.28 | -18.67 |
| EPS Diluted Total Ops | -30.60 | -25.20 | -21.60 | -18.00 | -18.00 |
| EPS Diluted Continuous Ops | -31.40 | -26.04 | -19.47 | -18.28 | -18.67 |
| EBITDA(a) | $-2,456 | $-1,843 | $-1,600 | $-1,127 | $-1,157 |